Retinal vessel structure measurement using spectral-domain optical coherence tomography – (Eye 30, 111 (January 2016))
Retinal vessel structure measurement using spectral-domain optical coherence tomography Eye 30, 111 (January 2016). doi:10.1038/eye.2015.205 Authors: T H Rim, Y S Choi, S S Kim, M-j Kang, J Oh, S Park & S H Byeon
High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos – (Eye 30, 120 (January 2016))
High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos Eye 30, 120 (January 2016). doi:10.1038/eye.2015.206 Authors: N Relhan, S Jalali, N Pehre, H L Rao, U Manusani & L Bodduluri
Prolonged organ culture reduces the incidence of endothelial immune reactions – (Eye 30, 127 (January 2016))
Prolonged organ culture reduces the incidence of endothelial immune reactions Eye 30, 127 (January 2016). doi:10.1038/eye.2015.207 Authors: P Maier, S Heinzelmann, D Böhringer & T Reinhard
South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experience – (Eye 30, 133 (January 2016))
South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experience Eye 30, 133 (January 2016). doi:10.1038/eye.2015.209 Authors: F Ghanchi & C A Hazel
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study – (Eye 30, 139 (January 2016))
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study Eye 30, 139 (January 2016). doi:10.1038/eye.2015.199 Authors: C Bruè, A Pazzaglia, C Mariotti, M Reibaldi & A Giovannini